You are now leaving GSK’s website 

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

This browser is no longer supported.

To provide you with the best possible experience, we kindly ask you to switch to a supported browser:

Google Chrome Mozilla Firefox Microsoft Edge

Not a healthcare professional? Visit our Public site

For Healthcare professionals

Not a healthcare professional? Visit our Public site

This site May contain promotional material

GSK Logo
Search

Report adverse event

Menu

Close

Close

Go to Cart

1    

  • My Orders
  • Communication preferences

Basket

User logged in

Overlay Text

GSK Logo

For Healthcare Professionals registered in Ireland

May contain promotional material

  • Products
  • Therapy areas
  • Resources
  • Events
  • Contact Us

 Registration successful

You now have access to the latest updates, events and resources.

 Registration successful

You now have successfully registered for the event and for an account on this website.

In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.

 Account activated – pending validation.

  Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

  In the meantime, you can enjoy access to all the latest news, events and resources on our website

 Registration completed – pending validation

  Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result of the validation process. Please note this could take up to 10 days.

  In the meantime, you can continue to access all the unlocked content on this website.

 

 Account activated - pending validation.

  Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result. Please note this could take up to 10 days.

 In the meantime, you can continue to access the unlocked content of the website.

 Registration completed - pending validation.

  Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result of the validation process. Please note this could take up 10 days.

  In the meantime, you can continue to access all the unlocked content on this website.

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

 already registered

X »

Anoro Ellipta 20 mcg

has been added to your basket

View Basket

Popup

59

  • ASYEVE0001=Event Registration-Portal
  • ASYEVE0002=Watched General Video
  • ASYEVE0003=Watched Virtual Rep Video
  • ASYEVE0004=Watched Patient Video
  • ASYEVE0005=Watched Expert Video
  • ASYEVE0006=Watched Webcast
  • ASYEVE0007=Downloaded Content-Portal
  • ASYEVE0008=Clicked to App Store
  • ASYEVE0009=Watched Learning Module Video
  • ASYEVE0010=eMail Sent
  • ASYEVE0011=eMail Read
  • ASYEVE0012=eMail Clicked
  • ASYEVE0013=Shared a Link
  • ASYEVE0014=Rep Request
  • ASYEVE0015=Joined health.gsk
  • ASYEVE0016=email Not Sent
  • ASYEVE0017=Email Not Sent
  • ASYEVE0018=Email Not Sent
  • ASYEVE0037=IJSFAID is not available
  • ASYEVE0038=EMAIL ID and IJSFAID is not available
  • ASYEVE0039=The user is opted out
  • ASYEVE0040=Scope IDs are different
  • ASYEVE0001=Event Registration-Portal
  • ASYEVE0002=Watched General Video
  • ASYEVE0003=Watched Virtual Rep Video
  • ASYEVE0004=Watched Patient Video
  • ASYEVE0005=Watched Expert Video
  • ASYEVE0006=Watched Webcast
  • ASYEVE0007=Downloaded Content-Portal
  • ASYEVE0008=Clicked to App Store
  • ASYEVE0009=Watched Learning Module Video
  • ASYEVE0010=eMail Sent
  • ASYEVE0011=eMail Read
  • ASYEVE0012=eMail Clicked
  • ASYEVE0013=Shared a Link
  • ASYEVE0014=Rep Request
  • ASYEVE0015=Joined health.gsk
  • ASYEVE0016=email Not Sent
  • ASYEVE0017=Email Not Sent
  • ASYEVE0018=Email Not Sent
  • ASYEVE0037=IJSFAID is not available
  • ASYEVE0038=EMAIL ID and IJSFAID is not available
  • ASYEVE0039=The user is opted out
  • ASYEVE0040=Scope IDs are different

Incruse Ellipta

umeclidinium bromide inhalation powder

Prescribing Information

Incruse Ellipta SPC

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

  • Incruse Ellipta
    • Indications
    • Administration

Request a contact

Stay informed

Live Chat

Product overview

Incruse Ellipta is used to treat chronic obstructive pulmonary disease (COPD) in adults. Incruse Ellipta exerts its bronchodilatory activity by competitively inhibiting the binding of acetylcholine with muscarinic cholinergic receptors on airway smooth muscle, making it easier for air to get in and out of the lungs. When used regularly, it can help control breathing difficulties and improve health-related quality of life. 1

Request a placebo

Woman using Ellipta device

Learn about the Ellipta inhaler

Learn more about the Ellipta inhaler and support patients to use their inhaler correctly

Learn more

Reference:

  1. Incruse Ellipta 55 mcg SPC; GlaxoSmithKline

Adverse events should be reported directly to the Health Products Regulatory
Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Incruse and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies

PM-IE-UCB-WCNT-200001 December 2024

Overlay

Get in touch

To discuss our products, supply, educational events or any other information

Contact us

  • Public site
  • Gsk.com
Change Country
  • Change country
  • Sitemap
  • Terms of use
  • Privacy notice

© 2025 to 2026 GlaxoSmithKline plc. All rights reserved.

Registered in Ireland: GlaxoSmithKline (Ireland) Limited, a private company limited by shares, and a member of the GlaxoSmithKline group of companies. Registered in Ireland with Company Number 15513.
Registered office: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.

PM-IE-NA-WCNT-230003

Sorry, this site is not supported on Android v4.3 and below.

Please update your operating system or use a different device.